We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: Fitzhughlaw who wrote (52479)9/13/2019 10:33:22 AM
From: stockdoc771 Recommendation

Recommended By

  Read Replies (2) | Respond to of 57518
On its face, they are certainly making a big deal out of their data as a significant event for investors. Would it be too much to conclude that the data is very good and the numbers large enough to support filing for BTD?

To: Fitzhughlaw who wrote (52479)9/13/2019 5:35:16 PM
From: Strongbio  Respond to of 57518
My guess is that the results are good enough to support the big pharma requirements to buy immu out and that will be announced sept 28 in the cc. It's just my opinion.